FIELD: medicine.
SUBSTANCE: method involves determining β-transforming growth factor concentration in mucous membrane of cervical canal. The value being equal to or greater than 240 pcg/ml, severe uterine cervix dysplasia case is to be diagnosed.
EFFECT: high reliability of diagnosis.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSTIC TECHNIQUE FOR DEGREE OF CERVICAL DYSPLASIA | 2019 |
|
RU2704966C1 |
| METHOD FOR PREDICTION OF PERSISTENCE OF ONCOGENIC HUMAN PAPILLOMA VIRUS IN CERVICAL EPITHELIUM | 2012 |
|
RU2520710C1 |
| METHOD FOR USING IMMUNOLOGICAL MARKERS FOR PREDICTION OF PROLIFERATIONS OF CERVICAL INTRAEPITHELIAL NEOPLASIAS ASSOCIATED WITH PAPILLOMAVIRUS INFECTION | 2012 |
|
RU2520746C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF CERVICAL INTRAEPITHELIAL NEOPLASIA OF III DEGREE AND PRE-INVASIVE CERVICAL CANCER, ASSOCIATED WITH HUMAN PAPILLOMA VIRUS | 2012 |
|
RU2506892C1 |
| METHOD OF PREDICTING PROGRESSION OF MILD INTRAEPITHELIAL NEOPLASIA IN WOMEN OF YOUNG AND FIRST PERIOD OF MATURE AGE | 2014 |
|
RU2572340C1 |
| DIAGNOSTIC TECHNIQUE FOR PAPILLOMA VIRUS INFECTION | 2008 |
|
RU2379690C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF BENIGN, PRECANCEROUS AND MALIGNANT CERVICAL NEOPLASMS | 2011 |
|
RU2477069C1 |
| METHOD FOR PREDICTING PRE-CANCER DISEASES OF UTERINE CERVIX IN WOMEN WITH PAPILLOMA-VIRAL INFECTION | 2006 |
|
RU2310197C1 |
| METHOD FOR TREATING PRECANCER UTERINE CERVIX DISEASE CASES | 2004 |
|
RU2271804C1 |
| METHOD FOR DETERMINING THE DEGREE OF CERVICAL DYSPLASIA | 2020 |
|
RU2758330C1 |
